Phase 2 Site definition

Phase 2 Site means those areas where the Phase 2 Liquefaction Facility will be located as further described in this Agreement and as shown in greater detail in Attachment 25.
Sample 1Sample 2Sample 3
Phase 2 Site means that portion of Sabine Pass at which the construction activity is being or shall be performed for the Phase 2 Project.
Sample 1Sample 2

Examples of Phase 2 Site in a sentence

  • Phase 2: Site investigation - to assess the contamination and the possible effect it could have on human health, pollution and damage to property.

  • Documents: IFB Number 21074 Moose Meadows Road Service Area Annual Maintenance Backup Information.pdf 9.j. IFB Award: IFB Number 21061 Construction and Demolition (C&D) Cell 5 Phase 2 Site Preparation Approval of Base Bid, as submitted by Great Northwest, Inc.

  • Phase 2: Site Evaluation/InspectionIn Phase 2: Site Evaluation/Inspection, bidders are required to achieve the minimum score of 80 points out of 100 to qualify for evaluation in Phase 3: Price and Broad-Based Black Economic Empowerment (B-BBEE).

  • Bid responses will be evaluated in accordance with the following criteria: Phase 1: Technical and Functional RequirementsBid responses that do not achieve the minimum score of 80 points out of 100 under Technical and Functional Requirements will not be considered for further evaluation in Phase 2: Site Evaluation/Inspection.

  • Authorization to Contract with Alpine Construction and Landscaping Corp for Chelsea Waterside Park Phase 2 Site and Landscape Work, E.W. Howell Co., LLC for Comfort Station Construction and Athletic Fields of America for the Athletic Field Turf ReplacementJ.

  • Bid responses that do not achieve the minimum score of 80 points out of 100 under Technical and Functional Requirements will not be considered for further evaluation in Phase 2: Site Evaluation/Inspection.

  • To date, a total of 48 Phase I and Phase 2 Site Assessments have been completed in the Montachusett Region.

  • Google Drive presentation included Site Development Plan Application with Phase 1 (existing) and Phase 2 renderings as well as existing Site Plan and Proposed Phase 2 Site Plan.

  • Samples shall be subject to review and materials represented by such samples shall not be manufactured, delivered to the Phase 2 Site or incorporated into the Work without such review.

  • The applicable portions of the Constitution and bylaws may be found at Appendix Two.

Related to Phase 2 Site

  • Phase 1 means the phase of the ATP comprised of: (1) improvements to the State Street Substation; (2) construction of the Proposed Line; (3) the rebuilding of NYSEG’s existing Lines 971 and 000 xxxxx xx Xxxxxxxx Xxxx xx the NYSEG ROW to allow for construction of the Proposed Line as intended; (4) improvements to the Elbridge Substation to accept the Proposed Line; and (5) National Grid’s conveyance to NYSEG of the NYSEG Acquired ROW and such other land interests as contemplated by the Purchase and Sale Agreement.

  • Phase II means the second part of the tuition incentive assistance program which provides assistance in the third and fourth year of 4-year degree programs.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase 2 means the phase of the ATP comprised of: (1) improvements to the State Street Substation to receive Rebuilt Line 972; (2) the rebuilding of NYSEG’s existing Line 972 not performed in Phase 1; (3) construction of Relocated Line 15; (4) the construction of Bused Line 5; (5) improvements to the Elbridge Substation to receive Relocated Line 15; and (6) improvements to the Elbridge Substation to receive Bused Line 5.

  • Phase III means human clinical trials, the principal purpose of which is to establish substantial evidence of both safety and efficacy in patients with the disease or condition being studied, as more fully defined in 21 C.F.R. §312.21(c) or similar clinical study in a country other than the United States. Phase III shall also include any other human clinical trial intended to serve as a pivotal trial to support the submission of an application for regulatory approval.

  • Phase 1 Study means a clinical study of a drug candidate in human patients with the primary objective of characterizing its safety, tolerability, and pharmacokinetics and identifying a recommended dose and regimen for future studies as described in 21 C.F.R. §312.21(a), or a comparable clinical study prescribed by the relevant Regulatory Authority in a country other than the United States. The drug candidate can be administered to patients as a single agent or in combination with other investigational or marketed agents.

  • Phase 2 Trial means a human clinical trial conducted on study subjects with the disease or condition being studied for the principal purpose of achieving a preliminary determination of efficacy or appropriate dosage ranges, as further described in 21 C.F.R. §312.21(b) (including any such clinical study in any country other than the United States).

  • Development Site means any parcel or lot on which exists or which is intended for building development other than the following:

  • Phase 3 means the period commencing on the day after the Phase 2 implementation date and ending on the Phase 3 implementation date (as defined below).

  • Project site, where applicable, means the place indicated in bidding documents.

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase I means the first part of the tuition incentive assistance program defined as the academic period of 80 semester or 120 term credits, or less, leading to an associate degree or certificate.

  • Project Site(s) means the place(s) specified in the SCC for the supply and installation of the System.

  • Phase 1 Trial means, with respect to a Licensed Product, a clinical trial (or — in case of a multi-phase clinical trial — those parts of a clinical trial) in line with the provisions of 21CFR312, Section 21 (a).

  • Phase I Trial means a Clinical Trial, the principal purpose of which is preliminary determination of safety of an investigational product in healthy individuals or patients or that otherwise meets the requirements described in 21 C.F.R. §312.21(a), or similar Clinical Trial in a country other than the United States.

  • Phase 3 Study means a clinical study of a drug candidate in human patients that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to obtain Regulatory Approval in any country as described in 21 C.F.R. 312.21(c), or a comparable clinical study prescribed by the relevant Regulatory Authority in a country other than the United States. The relevant drug candidate may be administered to patients as a single agent or in combination with other investigational or marketed agents.

  • Marijuana testing facility means an entity licensed to analyze and certify the safety and potency of marijuana.

  • The Project Site, where applicable, means the place or places named in the SCC.

  • Phase 3 Trial means a human clinical trial of a Product on a sufficient number of subjects that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which trial is intended to support Approval of a Product, as described in 21 C.F.R. 312.21(c) for the United States, or a similar clinical study prescribed by the Regulatory Authorities in a foreign country.

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Study Site means the location(s) under the control of the Institution where the Study is actually conducted as set out in Schedule 1.

  • The Site, where applicable, means the designated project place(s) named in the bidding document.

  • project completion period means the period of sixty (60) months commencing from and expiring on for the construction and obtaining of Temporary Occupation Permit or Permits for the whole of the Development as provided in clause 3.3;

  • Work Site means the site where the Work is being performed.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.